With respect Karen a K-ras mutation happens in 40% of colorectal patients so they routinely do the gene testing. K-ras mutations happen in around 5% of SCCHN patients so our wonderful health officials deem it "unnecessary".

I think it would be completely necessary if you are one of those 5% that it's not going to work on...wouldn't you? Now Karen I don't know your background or experience, but I've actually been in a closed meeting at the U.S. National Cancer Institute with Brian and Dr. Maura Gillison as she presented to the National Institute of Health for one of these studies. It's a numbers game to them, not an individual case (and by rights it has to be) but I would want to know.

I would also say that there are few people outside the medical community that has done more research into the treatment protocols and effects of oral cancer treatments then I have, I'm "very" familiar with what these drugs do, but thank you for the refresher. I'll remember this the next time I'm lecturing at the University of Washington, which has the #6 rated cancer care center in the U.S.